MAPT and Alzheimer disease: Currently, verification of an AD diagnosis occurs through postmortem detection of pathology in neural tissue, specifically extracellular amyloid plaques and intracellular neurofibrillary tau tangles; however, cognitive changes are discernible early during AD pathogenesis and mild cognitive impairment (MCI).